A single drop of blood can be fascinating to look at — but understanding what it can and can't tell you makes it far more useful.
Under a microscope, red blood cells, white blood cells, platelets and other material within a fresh blood sample become visible on a screen. Instead of receiving a laboratory report containing numbers and reference ranges, you can actually see some of the physical components of your own blood.
This is the basis of Live Blood Analysis, also called Live Blood Microscopy, Live Cell Analysis or Darkfield Blood Microscopy.
At Brilin Functional Medicine Centre, we use Live Blood Analysis as an observational and educational wellness tool. It can provide an interesting visual snapshot of a fresh blood sample and can sometimes raise questions worth investigating further.
But there is an equally important part of the story: Live Blood Analysis is not a replacement for laboratory blood testing and should not be used to diagnose disease. Understanding that distinction makes Live Blood Analysis much more useful, because we can appreciate what is genuinely visible under the microscope without turning every shape, particle or pattern into a medical diagnosis.
In This Guide
- What is Live Blood Analysis?
- What can actually be seen?
- Red blood cell aggregation and rouleaux
- Can it detect nutritional deficiencies?
- How reliable is it?
- Why does Brilin use it?
- What is Dry Blood Analysis?
- Dry Blood vs Dried Blood Spot testing
- How is laboratory blood testing different?
- Live Blood Analysis at Brilin
What Is Live Blood Analysis?
Live Blood Analysis involves obtaining a small sample of fresh capillary blood, usually from a fingertip. The drop is placed onto a glass microscope slide, covered with a coverslip and examined shortly afterwards.
Unlike many conventional laboratory blood investigations, the sample is normally viewed without first being dried, chemically stained, centrifuged or separated into serum and plasma. At Brilin, the microscope image is displayed on a monitor so the client and practitioner can observe the sample together.
The word "live" can occasionally cause confusion. It simply means the blood is being observed while it is fresh rather than after the preparation and staining used for a conventional laboratory blood film. It does not mean that the blood remains in its normal physiological state once it has left the circulation. From the moment a drop is placed on a slide it begins being affected by its new environment, including contact with glass, oxygen, temperature, evaporation and pressure from the coverslip.
That is one reason interpretation requires caution.
What Is Darkfield Microscopy?
Live blood is commonly viewed using darkfield microscopy. Darkfield microscopy is an established optical microscopy technique. Instead of illuminating the specimen in the same way as a standard brightfield microscope, direct light is largely excluded from the objective while light scattered by objects in the specimen enters it.
The result is the characteristic appearance of bright cells and structures against a dark background. This can make transparent, unstained structures easier to see and creates the striking images commonly associated with Live Blood Analysis.
There is nothing inherently controversial about darkfield microscopy itself. It is simply an optical technique. The important scientific question is what conclusions can legitimately be drawn from what is seen.
What Can Actually Be Seen?
A fresh blood sample contains several structures that can genuinely be observed microscopically.
Red Blood Cells
Red blood cells, or erythrocytes, dominate most fields. Their primary biological role is to transport oxygen using haemoglobin. Under microscopy we can observe their general appearance, relative size, shape, distribution and whether they appear predominantly separate or aggregated. Individual cells may appear fairly uniform, while others may appear irregular, crenated, elongated or differently sized.
These are observations. They are not diagnoses. Cell appearance can potentially be influenced by the person's physiology, but it can also be influenced by how the sample was collected and prepared, where on the slide it is being viewed and how long it has been sitting outside the circulation.
White Blood Cells
Larger cells compatible with white blood cells can also be observed. White blood cells are part of the immune system and occur in much smaller numbers than red blood cells. However, seeing several white blood cells within a particular microscopic field does not establish that somebody has an infection or an overactive immune system.
A conventional Full Blood Count with differential actually measures white blood cell numbers and the proportions of neutrophils, lymphocytes, monocytes, eosinophils and basophils. Healthify New Zealand notes that the Full Blood Count is a standard laboratory test used alongside symptoms, medical history and other investigations to help assess a wide range of conditions.
Platelets and Small Particles
Platelets and various small particles may also be visible. The difficulty is that not every small dot or moving structure can be reliably identified simply by appearance. Depending on the sample, small structures could represent platelets, cellular fragments, precipitated material, proteins, contamination, optical artefacts or other material.
For that reason, Brilin does not regard an unidentified microscopic particle as proof of bacteria, parasites, Candida or another microorganism. A suspected bloodstream infection, for example, requires appropriate medical assessment and laboratory microbiology testing. Live Blood Analysis cannot establish that diagnosis.
Red Blood Cell Aggregation and Rouleaux
One of the most visually striking findings in fresh blood can be red blood cell aggregation. Instead of appearing predominantly as separate cells, red cells may form chains or clusters. When cells line up in a configuration resembling stacks of coins, the appearance is called rouleaux.
Rouleaux is a genuine phenomenon recognised in conventional haematology. Increased concentrations of plasma proteins, particularly fibrinogen and immunoglobulins, can promote red-cell aggregation. The American Society of Hematology describes this classic stack-of-coins pattern and notes that genuine rouleaux may be associated with increased plasma proteins.
But there is an important complication. Even in conventional blood-film work, apparent rouleaux may be affected by preparation technique or by examining a particularly thick area of a slide. A fresh wet-mount sample introduces additional variables including sample thickness, time after collection, drying, coverslip pressure and the area being observed.
Therefore: Seeing aggregation is a legitimate observation. Determining why it is there is a different question.
If marked aggregation appears repeatedly and is considered relevant to the person's history or symptoms, conventional testing may be more useful than trying to infer the cause from the image alone. Depending on the circumstances, a healthcare professional may consider investigations such as a Full Blood Count, ESR, CRP, total protein, albumin/globulin measurements or a conventional peripheral blood film.
This is a good example of how Live Blood Analysis can potentially generate a question that is then investigated with the appropriate diagnostic tool.
Can Live Blood Analysis Detect Nutritional Deficiencies?
This is an interesting area because there is some published research, but considerably less evidence than is sometimes suggested.
It is already well established in conventional haematology that nutritional deficiencies can affect blood-cell morphology. Iron deficiency, vitamin B12 deficiency and folate deficiency can alter red-cell production, size and shape. The question is whether fresh capillary blood viewed using darkfield microscopy can reliably identify those deficiencies.
A 2016 study by Sheriden Keegan, Jacinta Arellano and Tini Gruner specifically investigated this question. Twenty-nine participants underwent fresh capillary darkfield microscopy followed by conventional pathology testing. The researchers found associations between several microscopic parameters and biochemical measures of iron and vitamin B12 status. Elliptocytosis performed best among the studied markers for low iron, while anisocytosis performed best for low cobalamin/B12.
That study is worth discussing because it represents an attempt to test particular Live Blood Analysis observations against conventional pathology rather than simply assuming the associations exist. But it also needs to be kept in perspective. It involved only 29 participants. The authors themselves stated that further research was required to validate the parameters studied.
It therefore does not justify treating Live Blood Analysis as a diagnostic test for iron or B12 deficiency, let alone using it to diagnose a broad range of nutritional deficiencies. If iron deficiency is suspected, appropriate laboratory investigations might include haemoglobin, ferritin and iron studies. If vitamin B12 deficiency is suspected, appropriate biochemical testing should be used. Live Blood Analysis may provide an observation worth discussing, but the laboratory test answers the diagnostic question.
How Reliable Is Live Blood Analysis?
Reliability is another important issue. One published pilot study examined the reproducibility of Enderlein-style darkfield live blood analysis. Teut, Lüdtke and Warning asked two experienced practitioners to assess 48 capillary blood samples from 24 people with diabetes. Agreement between the two observers was relatively low, with an inter-observer kappa of 0.35. When the assessments were repeated, test-retest reliability was also limited, with a kappa of 0.44.
The researchers concluded that Enderlein darkfield analysis was difficult to standardise and that the reliability of the diagnostic method was low. That study does not mean that a microscope cannot show real blood cells or genuine morphological features. It means something more specific and important: broad diagnostic interpretation of live-blood patterns has not demonstrated the reproducibility expected from a validated medical diagnostic test.
That is why Brilin separates what we can see from what we can prove.
What Live Blood Analysis Cannot Establish
Live Blood Analysis should not be used to determine a person's blood glucose, ferritin, vitamin B12, vitamin D, cholesterol, thyroid hormones, liver enzymes, kidney function, CRP, haemoglobin concentration, platelet count, arterial oxygen saturation or blood pH.
Nor should a live blood image be used by itself to diagnose cancer, diabetes, anaemia, sepsis, autoimmune disease, cardiovascular disease, liver or kidney disease, parasitic infection, Candida overgrowth, heavy-metal toxicity or another medical condition. Some of those conditions can affect blood morphology, but observing an appearance and determining its cause are two very different things.
Why Does Brilin Use Live Blood Analysis?
If Live Blood Analysis is not a replacement for pathology, a reasonable question is: Why use it at all? For us, there are three practical reasons.
It Makes Health Visible
Most people have had blood tests but have never seen their own blood. Viewing the sample together can be an engaging educational experience. Instead of discussing red cells, white cells and platelets as abstract concepts, clients can actually see some of those structures. That can make conversations around health considerably easier to understand.
It Can Prompt Better Questions
Occasionally we see something that appears unusual enough to justify asking another question. Rather than concluding, for example, that marked red-cell aggregation proves inflammation, we can say: "There is substantial aggregation here. There are several possible explanations. Is there anything in your history or conventional testing that helps explain it, and is further testing appropriate?" That is a much more useful approach than pretending the microscope has already supplied the diagnosis.
It Adds Context to a Wider Consultation
At Brilin we rarely look at one piece of information in isolation. We consider symptoms, health history, diet, lifestyle, existing medical results and other assessments together. Live Blood Analysis can be another observational element within that wider conversation.
It is also completely optional. A person does not need to undergo Live Blood Analysis to participate in a Brilin programme or receive functional-health support. We do not believe the value of the service depends on making dramatic claims about what a microscope can supposedly diagnose. The value is in education, engagement, observation and asking better questions.
What Is Dry Blood Analysis?
Dry Blood Analysis is a different technique. Instead of immediately covering and viewing a fresh blood drop, drops of blood are placed on a slide and allowed to clot and dry. The resulting dried patterns can then be examined microscopically.
As a blood droplet dries, evaporation, blood cells, proteins and other components interact to create cracks, rings, clear areas, dense areas and other structural patterns. There is genuine scientific research into the physics and potential diagnostic applications of dried biological droplets.
For example, a 2024 experimental study published in Colloids and Surfaces B: Biointerfaces examined dried blood droplets on vertical surfaces and found that haematocrit — the proportion of blood made up of red blood cells — significantly affected drying behaviour and the resulting deposit. That study is scientifically interesting, but it should not be confused with validation of the health interpretations sometimes used in complementary Dry Blood Analysis.
The researchers used controlled samples, measured variables and quantitative image analysis. Their findings do not establish that an ordinary dried-blood pattern can be visually interpreted to diagnose liver dysfunction, toxicity, oxidative stress or particular diseases. The appearance of a dried drop can be affected by factors including blood composition, haematocrit, droplet volume, temperature, humidity, surface properties and the drying environment. That makes simplistic pattern interpretation problematic.
A crack or clear region may genuinely be visible. The scientific question is whether there is sufficient validated evidence to say exactly what that particular pattern means clinically. For most broad Dry Blood Analysis claims, that evidence is currently lacking.
Live Blood Analysis vs Dry Blood Analysis
The easiest way to understand the distinction is that Live Blood Analysis concentrates on structures within a fresh sample, whereas Dry Blood Analysis concentrates on the pattern produced after a blood drop has dried. Live Blood Analysis may show individual red cells, some white cells, platelets, aggregation and other material while the sample remains fresh. Dry Blood Analysis examines the physical deposit left after evaporation and clotting. Neither should be confused with standard diagnostic laboratory testing.
There is also another blood-testing method with a very similar name that is scientifically quite different.
Dry Blood Analysis vs Dried Blood Spot Testing
Dried Blood Spot testing, usually abbreviated DBS, is a genuine laboratory specimen-collection method. It is not the same thing as Dry Blood Analysis.
With DBS, blood is placed onto specialised filter paper, allowed to dry and then sent to a laboratory. The laboratory extracts material from the blood spot and uses an appropriate validated analytical method to measure particular substances. The scientific literature documents DBS applications ranging from newborn metabolic screening to drug monitoring and the measurement of numerous proteins, metabolites, nucleic acids and other biomarkers. Validation remains necessary for each particular assay because factors such as haematocrit and storage conditions can affect results.
New Zealand provides an excellent real-world example. Health New Zealand's Newborn Metabolic Screening Programme collects small drops of blood from a baby's heel onto a blood-spot card. That card is sent to a screening laboratory and tested for specific rare but serious disorders. The laboratory is analysing substances contained within the dried blood. It is not looking at the visual shape of the dried stain and interpreting cracks or patterns. That is the crucial distinction.
How Is Laboratory Blood Testing Different?
Conventional laboratory blood testing generally asks specific, measurable questions. A Full Blood Count measures parameters including red blood cell numbers, haemoglobin, haematocrit, mean cell volume, white blood cell numbers, white-cell differential and platelets. Blood chemistry can measure substances such as glucose, electrolytes, enzymes, proteins and markers relating to kidney, liver and other physiological functions. Healthify describes blood tests as one of the most commonly used forms of medical investigation in New Zealand.
These tests use validated analytical methods, quality-control procedures and defined reference intervals. That allows a clinician to ask a precise question such as: "What is this person's ferritin concentration?" and receive a quantitative result. Live Blood Analysis cannot do that. It answers a different question: "What does this small fresh sample look like under the microscope right now?" Those are both legitimate questions, but they are not equivalent.
What About a Laboratory Blood Smear?
A conventional peripheral blood smear, or blood film, is particularly useful for comparison because it also involves looking at blood under a microscope. In this case, blood is spread thinly across a slide and specially stained. A trained laboratory professional can then assess the size, shape and appearance of red cells, white cells and platelets. Blood smears can be used alongside other testing to investigate blood and bone-marrow disorders, infections and certain parasites.
Even then, MedlinePlus emphasises that a blood smear is normally interpreted alongside other investigations rather than acting as a stand-alone diagnosis. That illustrates an important principle: Even validated laboratory microscopy is interpreted within context.
What Do Regulators Say About Live Blood Analysis Claims?
The UK's Advertising Standards Authority has specifically considered Live Blood Analysis advertising. Its guidance states that it has not seen sufficient evidence to support claims that Live Blood Analysis can diagnose conditions, vitamin deficiencies, allergies, general health problems or future health risks.
For a New Zealand clinic, however, the local rules are more important. New Zealand's Advertising Standards Authority requires therapeutic and health advertising to be truthful, balanced and not misleading. Claims must be capable of substantiation, and the ASA states that substantiation should be based on sound, relevant, clear and robust evidence. The New Zealand Commerce Commission similarly states that businesses must have reasonable grounds for representations at the time they make them and that health-related claims must not mislead consumers.
That is one reason Brilin takes a deliberately cautious approach to the language used around Live Blood Analysis. We believe it is more credible to explain both the strengths and the limitations of the technique than to claim that every visible blood pattern has a proven medical meaning.
Live Blood Analysis at Brilin
At Brilin, a Live Blood Analysis session begins with a small finger-prick sample obtained using a sterile single-use lancet. The fresh sample is placed on a glass slide and viewed under darkfield microscopy. The microscope image is displayed on a monitor so you can observe your blood with us and we can explain what is physically visible.
The session takes approximately 15 minutes and can be booked as a standalone service or included within selected Brilin consultation packages. It is currently available by appointment at our Ferrymead, Christchurch and Gleniti, Timaru clinics.
If something appears noteworthy, our approach is not to leap to a diagnosis. Instead, we consider the observation alongside your health history and other available information. Where appropriate, we may suggest discussing conventional investigation with your GP or another qualified healthcare professional.
So Which Type of Blood Testing Is Better?
There really isn't a sensible competition between them. They answer different questions. If you need to know whether you are anaemic, whether your ferritin is low, whether your CRP is elevated, whether your thyroid function is abnormal or whether your blood glucose is too high, laboratory testing is the appropriate tool.
If you want to observe your fresh blood under a microscope, learn about some of the cells you are looking at, discuss visible patterns and use that experience as part of a wider health conversation, Live Blood Analysis can offer something quite different. Dry Blood Analysis provides yet another type of observation, but interpretations of dried patterns should be treated cautiously and should not be confused with validated laboratory Dried Blood Spot testing.
At Brilin, our position is simple: Use the right tool for the right question. Live Blood Analysis can be interesting, educational and thought-provoking without pretending to be something it is not. Sometimes the most useful outcome isn't a diagnosis from a microscope. It is recognising something worth asking about and knowing what to investigate next.
See your own blood in real time
Book a Live Blood Analysis session at our Ferrymead (Christchurch) or Gleniti (Timaru) clinic — standalone or as part of a consultation package.
Book a SessionFrequently Asked Questions
Can Live Blood Analysis diagnose disease?+−
No. Live Blood Analysis is not a validated medical diagnostic test and should not be used to diagnose or exclude disease. Medical conditions require appropriate clinical assessment and, where necessary, validated laboratory testing or imaging.
Can Live Blood Analysis tell whether I am deficient in vitamins or minerals?+−
Certain changes in blood-cell morphology can be associated with nutritional deficiencies, and a small 2016 study found correlations between particular fresh-blood microscopy features and laboratory markers of iron and vitamin B12 status. However, this does not make Live Blood Analysis a replacement for conventional nutrient testing.
Is Live Blood Analysis the same as a blood smear?+−
No. A medical laboratory blood smear involves a specially prepared and stained blood film interpreted using established haematological methods. Live Blood Analysis generally examines an unstained fresh capillary sample.
Is Dry Blood Analysis the same as Dried Blood Spot testing?+−
No. Dry Blood Analysis visually examines patterns created as a blood drop dries. Dried Blood Spot testing uses dried blood as a specimen that is subsequently analysed using laboratory methods. New Zealand's newborn heel-prick programme is an example of legitimate blood-spot laboratory testing.
Is Live Blood Analysis compulsory at Brilin?+−
No. It is an optional assessment. It can be booked independently or forms part of some consultation packages, but it is not required in order to work with Brilin.
References and Further Reading
- Keegan S, Arellano JM, Gruner T. Fresh capillary blood analysis using darkfield microscopy as a tool for screening nutritional deficiencies of iron and cobalamin (vitamin B12): A validity study. Advances in Integrative Medicine. 2016;3(1):15–21. DOI: 10.1016/j.aimed.2016.01.001.
- Teut M, Lüdtke R, Warning A. Reliability of Enderlein's darkfield analysis of live blood. Alternative Therapies in Health and Medicine. 2006;12(4):36–41.
- Pérez Hidalgo RB et al. Dried blood drops on vertical surfaces. Colloids and Surfaces B: Biointerfaces. 2024;234:113716. DOI: 10.1016/j.colsurfb.2023.113716.
- Enderle Y, Foerster K, Burhenne J. Clinical feasibility of dried blood spots: Analytics, validation, and applications. Journal of Pharmaceutical and Biomedical Analysis. 2016;130:231–243.
- Health New Zealand | Te Whatu Ora. Heel prick test — newborn metabolic screening.
- Healthify New Zealand. Full blood count (FBC) and Blood tests.
- MedlinePlus. Blood Smear. US National Library of Medicine.
- Advertising Standards Authority New Zealand. Therapeutic and Health Advertising Code and Guidance Note on Advertising Health Services.
- Commerce Commission New Zealand. Making accurate claims.

